Demyelinating disorders: Update on transverse myelitis

Current Neurology and Neuroscience Reports

Volumn 6, Issue 3, 2006, Pages 236-243

  Krishnan, Chitra ^b   Kaplin, Adam I ^b   Pardo, Carlos A ^b   Kerr, Douglas A ^b   Keswani, Sanjay C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BACLOFEN; BOTULINUM TOXIN; CYCLOPHOSPHAMIDE; DANTROLENE; DIAZEPAM; ERYTHROPOIETIN; IMMUNOMODULATING AGENT; INTERLEUKIN 6; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; NEUROIMMUNOPHILIN; NEUROPROTECTIVE AGENT; NEUROTROPHIN 3; STEROID; TIAGABINE; TIZANIDINE;

ARTICLE; AUTONOMIC NEUROPATHY; AXONAL INJURY; BLADDER DYSFUNCTION; CELL INFILTRATION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; CYTOPENIA; DEMYELINATING DISEASE; DEMYELINATION; FILTRATION; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; LONGITUDINAL STUDY; LYMPHOCYTIC INFILTRATION; MONOCYTE; MOTOR NEUROPATHY; MYELITIS; PARAPLEGIA; PARESTHESIA; PLASMAPHERESIS; PREDICTION; REHABILITATION CARE; SENSORY NEUROPATHY; SPASTICITY; SPINAL CORD DISEASE;

BIOLOGICAL MARKERS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DEMYELINATING DISEASES; HUMANS; MYELITIS, TRANSVERSE; NEUROPROTECTIVE AGENTS; STEROIDS;

EID: 33646822122     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-006-0011-1     Document Type: Article

References (33)

1. Berman M, Feldman S, Alter M, et al.: Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981, 31:966-971.
2. Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499-505.
3. Achiron A, Barak Y. Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol 2000, 57:974-979.
4. Jeffery DR, Mandler RN, Davis LE: Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993, 50:532-535.
5. Christensen PB, Wermuth L, Hinge HH, Bomers K: Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 1990, 81:431-435.
6. Altrocchi PH: Acute transverse myelopathy. Arch Neurol 1963, 9:21-29.
7. Paine RS, Byers RK: Transverse myelopathy in childhood. AMA Am J Dis Child 1968, 85:151-163.
8. Knebusch M, Strassburg HM, Reiners K: Acute transverse myelitis in childhood: nine cases and review of the literature. Dev Med Child Neurol 1998, 40:631-639.
9. Dunne K, Hopkins IJ, Shield LK: Acute transverse myelopathy in childhood. Dev Med Child Neurol 1986, 28:198-204.
10. Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturition disturbance in acute transverse myelitis. Spinal Cord 1996, 34:481-485.
11. Burns AS, Rivas DA, Ditunno JF: The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 2001, 26:S129-S136.
12. DasGupta R, Fowler CJ: Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol 2002, 15:271-278.
13. Patten SB, Metz LM: Depression in multiple sclerosis. Psychother Psychosom 1997, 66:286-292.
14. Hummers LK, Krishnan C, Casciola-Rosen L, et al.: Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004, 62:147-149.
15. Ropper AH, Poskanzer DC: The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978, 4:51-59.
16. Irani DN, Kerr DA: 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000, 355:901.
17. Nagaswami S, Kepes J, Foster DB, Twemlow SW: Necrotizing myelitis: a clinico-pathologic report of two cases associated with diplococcus pneumoniae and mycoplasma pneumoniae infections. Trans Am Neurol Assoc 1973, 98:290-292.
18. Mirich DR, Kucharczyk W, Keller MA, Deck J: Subacute necrotizing myelopathy: MR imaging in four pathologically proved cases. Am J Neuroradiol 1991, 12:1077-1083.
19. Katz JD, Ropper AH: Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol 2000, 57:355-361.
20. Brocke S, Hausmann S, Steinman L, Wucherpfennig KW: Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin Immunol 1998, 10:57-67.
21. Kaplin AI, Krishnan C, Deshpande DM, et al.: Diagnosis and management of acute myelopathies. Neurologist 2005, 11:2-18.
22. Elovaara I, Lalla M, Spare E, et al.: Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology 1998, 51:1703-1708.
23. Sellebjerg F, Christiansen M, Jensen J, Frederiksen JL: Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Eur J Neurol 2000, 7:281-289.
24. Bracken MB, Shepard MJ, Collins WF, et al.: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990, 322:1405-1411.
25. Defresne P, Meyer L, Tardieu M, et al.: Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001, 71:272-274.
26. Lahat E, Pillar G, Ravid S, et al.: Rapid recovery from transverse myelopathy in children treated with methyl-prednisolone. Pediatr Neurol 1998, 19:279-282.
27. Sebire G, Hollenberg H, Meyer L, et al.: High dose methyl-prednisolone in severe acute transverse myelopathy. Arch Dis Child 1997, 76:167-168.
28. Kalita J, Misra UK: Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord 2001, 39:471-476.
29. Weinshenker BG: Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system. J Clin Apheresis 2001, 16:39-42.
30. Weinshenker BG: Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apheresis 1999, 14:144-148.
31. Weinshenker BG, O'Brien PC, Petterson TM, et al.: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878-886.
32. Keegan M, Pineda AA, McClelland RL, et al.: Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002, 58:143-146.
33. Wollinsky KH, Hulser PJ, Brinkmeier H, et al.: CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial. Neurology 2001, 57:774-780.